Northern Trust
SKYE icon

Northern Trust’s Skye Bioscience SKYE Stock Holding History

Northern Trust’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Hold
20,142
– – ﹤0.01% 4369
2025
Q4 		$15.1K Sell
20,142
-8,862
-31% -$12.9K ﹤0.01% 4412
2025
Q3 		$114K Hold
29,004
– – ﹤0.01% 4106
2025
Q2 		$121K Sell
29,004
-108,563
-79% -$225K ﹤0.01% 4069
2025
Q1 		$219K Buy
137,567
+1,855
+1% +$5.06K ﹤0.01% 3914
2024
Q4 		$384K Sell
135,712
-5,170
-4% -$21.6K ﹤0.01% 3751
2024
Q3 		$551K Buy
140,882
+98,413
+232% +$552K ﹤0.01% 3555
2024
Q2 		$340K Buy
+42,469
New +$504K ﹤0.01% 3650

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM